JPH0480914B2 - - Google Patents

Info

Publication number
JPH0480914B2
JPH0480914B2 JP57147008A JP14700882A JPH0480914B2 JP H0480914 B2 JPH0480914 B2 JP H0480914B2 JP 57147008 A JP57147008 A JP 57147008A JP 14700882 A JP14700882 A JP 14700882A JP H0480914 B2 JPH0480914 B2 JP H0480914B2
Authority
JP
Japan
Prior art keywords
formula
compound
aryl
carbon atoms
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57147008A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5877881A (ja
Inventor
Tee Ashuton Uooresu
Dee Kaakasu Jon
Kee Fuiirudo Aasaa
Eru Toruman Richaado
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JPS5877881A publication Critical patent/JPS5877881A/ja
Publication of JPH0480914B2 publication Critical patent/JPH0480914B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
JP57147008A 1981-08-26 1982-08-26 抗ウイルス性化合物 Granted JPS5877881A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29660481A 1981-08-26 1981-08-26
US296604 1981-08-26

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP3084272A Division JPH0729979B2 (ja) 1981-08-26 1991-04-16 抗ウィルス性化合物
JP4115111A Division JPH0714938B2 (ja) 1981-08-26 1992-03-24 抗ウイルス性化合物

Publications (2)

Publication Number Publication Date
JPS5877881A JPS5877881A (ja) 1983-05-11
JPH0480914B2 true JPH0480914B2 (enEXAMPLES) 1992-12-21

Family

ID=23142740

Family Applications (3)

Application Number Title Priority Date Filing Date
JP57147008A Granted JPS5877881A (ja) 1981-08-26 1982-08-26 抗ウイルス性化合物
JP3084272A Expired - Lifetime JPH0729979B2 (ja) 1981-08-26 1991-04-16 抗ウィルス性化合物
JP4115111A Expired - Lifetime JPH0714938B2 (ja) 1981-08-26 1992-03-24 抗ウイルス性化合物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP3084272A Expired - Lifetime JPH0729979B2 (ja) 1981-08-26 1991-04-16 抗ウィルス性化合物
JP4115111A Expired - Lifetime JPH0714938B2 (ja) 1981-08-26 1992-03-24 抗ウイルス性化合物

Country Status (14)

Country Link
EP (1) EP0074306B1 (enEXAMPLES)
JP (3) JPS5877881A (enEXAMPLES)
KR (1) KR840001168A (enEXAMPLES)
AT (1) ATE34750T1 (enEXAMPLES)
AU (1) AU8755282A (enEXAMPLES)
CA (1) CA1300622C (enEXAMPLES)
DE (1) DE3278561D1 (enEXAMPLES)
DK (1) DK379782A (enEXAMPLES)
ES (2) ES515193A0 (enEXAMPLES)
GR (1) GR76861B (enEXAMPLES)
IL (1) IL66640A0 (enEXAMPLES)
NZ (1) NZ201662A (enEXAMPLES)
PT (1) PT75463B (enEXAMPLES)
ZA (1) ZA826196B (enEXAMPLES)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6964890B1 (en) 1992-03-17 2005-11-15 Semiconductor Energy Laboratory Co., Ltd. Semiconductor device and method for forming the same
US7038302B2 (en) 1993-10-12 2006-05-02 Semiconductor Energy Laboratory Co., Ltd. Glass substrate assembly, semiconductor device and method of heat-treating glass substrate

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5157120A (en) * 1980-09-16 1992-10-20 Syntex (U.S.A.) Inc. Guanine derivatives
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
ES514877A0 (es) * 1981-08-11 1983-10-01 Wellcome Found "un procedimiento para preparar derivados de purina".
US4816447A (en) * 1981-08-26 1989-03-28 Merck & Co., Inc. Anti-viral guanine compounds
ZA83626B (en) * 1982-02-01 1983-12-28 Syntex Inc Substituted 9-(1 or 3-monoacyloxy or 1, 3-diacyloxy-2-propoxy-methyl purines as antiviral agent
US5250535A (en) * 1982-02-01 1993-10-05 Syntex Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
US4556659A (en) * 1982-08-09 1985-12-03 Syntex (U.S.A.) Inc. Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted propoxymethyl)-purines as antiviral agents
ES8507550A1 (es) * 1982-09-30 1985-09-16 Syntex Inc Procedimiento para la preparacion de 1-esteres monofosfato, 1,3-bis-esteres fosfato y esteres fosfato ciclico de 9-(1,3-dihidroxi-2-propoximetil)-guanina
US4544634A (en) * 1982-10-14 1985-10-01 Burroughs Wellcome Co. Method of producing acyclovir
US4609662A (en) * 1982-10-14 1986-09-02 Burroughs Wellcome Co. Method for using purine derivatives
US4462986A (en) * 1982-11-04 1984-07-31 Ens Bio Logicals, Inc. Synergistic anti-herpes compositions
US5047533A (en) * 1983-05-24 1991-09-10 Sri International Acyclic purine phosphonate nucleotide analogs
EP0274025A3 (en) * 1983-05-24 1990-08-29 Sri International Novel antiviral agents
JPS6023380A (ja) * 1983-06-24 1985-02-05 メルク・エンド・カムパニー・インコーポレーテッド 抗ウイルス剤
PT78769A (en) * 1983-06-24 1984-07-01 Merck & Co Inc Process for preparing (s)-9-(2,3-dihydroxy-1-propoxymethyl)guanine and derivatives thereof useful as antiviral agents
US4880820A (en) * 1983-06-24 1989-11-14 Merck & Co., Inc. Guanine derivatives
US4670424A (en) * 1983-09-19 1987-06-02 Merck & Co., Inc. Cyclic pyrophosphates of purine and pyrimidine acyclonucleosides
EP0138683A3 (en) * 1983-09-30 1988-01-20 Merck & Co. Inc. Purine derivatives, their application in anti-viral compositions
US4897479A (en) * 1983-09-30 1990-01-30 Merck & Co., Inc. Arylsulfonyloxy purine intermediates
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
EP0152316B1 (en) * 1984-01-26 1989-07-26 Merck & Co. Inc. Substituted butyl guanines and their utilization in antiviral compositions
US4579849A (en) * 1984-04-06 1986-04-01 Merck & Co., Inc. N-alkylguanine acyclonucleosides as antiviral agents
EP0184473A1 (en) * 1984-10-26 1986-06-11 Merck & Co. Inc. Regioselective synthesis of 9-substituted purine acyclonucleoside derivatives
JPH075595B2 (ja) * 1984-12-12 1995-01-25 シンテツクス（ユー・エス・エイ）インコーポレイテツド ９―（１，３―ジヒドロキシ―２―プロポキシメチル）グアニン類化合物の製法
SE8406538D0 (sv) 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
CA1330794C (en) * 1987-03-27 1994-07-19 Phillip Frost Anti-viral compounds, dosage forms and methods
US4966895A (en) * 1989-02-02 1990-10-30 Merck & Co. Inc. Cyclic monophosphates of purine and pyrimidine acyclonucleosides as anti-retroviral agents
US5068119A (en) * 1990-09-28 1991-11-26 Nabisco Brands, Inc. Acid-hydrolyzable ester derivatives as low calorie fat mimetics
GB2260319B (en) 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
US5532225A (en) * 1992-07-31 1996-07-02 Sri International Acyclic purine phosphonate nucleotide analogs as antiviral agents, and related synthetic methods
US5565565A (en) * 1994-08-04 1996-10-15 Syntex (U.S.A.) Inc. Preparation of N-9 substituted guanine compounds
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
CN1091445C (zh) * 1999-12-29 2002-09-25 湖北省医药工业研究院 抗病毒药物中间体、它们的制备及应用
WO2004039808A2 (en) * 2002-10-31 2004-05-13 Ranbaxy Laboratories Limited Process for the preparation of ganciclovir
CN113024559B (zh) * 2019-12-25 2022-03-29 上药康丽（常州）药业有限公司 一种异更昔洛韦的制备方法
KR20240077879A (ko) * 2022-11-25 2024-06-03 롯데케미칼 주식회사 올레핀 올리고머화의 부산물 저감 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146715A (en) * 1975-08-27 1979-03-27 Burroughs Wellcome Co. 2-amido-9-(2-acyloxyethoxymethyl)hypoxanthines
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
ES514877A0 (es) * 1981-08-11 1983-10-01 Wellcome Found "un procedimiento para preparar derivados de purina".
ZA83626B (en) * 1982-02-01 1983-12-28 Syntex Inc Substituted 9-(1 or 3-monoacyloxy or 1, 3-diacyloxy-2-propoxy-methyl purines as antiviral agent

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6964890B1 (en) 1992-03-17 2005-11-15 Semiconductor Energy Laboratory Co., Ltd. Semiconductor device and method for forming the same
US7564057B1 (en) 1992-03-17 2009-07-21 Semiconductor Energy Laboratory Co., Ltd. Semiconductor device having an aluminum nitride film
US7038302B2 (en) 1993-10-12 2006-05-02 Semiconductor Energy Laboratory Co., Ltd. Glass substrate assembly, semiconductor device and method of heat-treating glass substrate

Also Published As

Publication number Publication date
IL66640A0 (en) 1982-12-31
ES8402837A1 (es) 1984-03-01
KR840001168A (ko) 1984-03-28
JPH0729979B2 (ja) 1995-04-05
PT75463A (en) 1982-09-01
EP0074306B1 (en) 1988-06-01
JPH0714938B2 (ja) 1995-02-22
ZA826196B (en) 1984-04-25
CA1300622C (en) 1992-05-12
JPH04217940A (ja) 1992-08-07
ES522456A0 (es) 1984-08-01
NZ201662A (en) 1986-07-11
AU8755282A (en) 1983-03-03
JPH05286974A (ja) 1993-11-02
PT75463B (en) 1986-08-28
DE3278561D1 (en) 1988-07-07
DK379782A (da) 1983-02-27
EP0074306A2 (en) 1983-03-16
ES8406547A1 (es) 1984-08-01
EP0074306A3 (en) 1983-05-25
ES515193A0 (es) 1984-03-01
ATE34750T1 (de) 1988-06-15
GR76861B (enEXAMPLES) 1984-09-04
JPS5877881A (ja) 1983-05-11

Similar Documents

Publication Publication Date Title
JPH0480914B2 (enEXAMPLES)
US4808716A (en) 9-(phosponylmethoxyalkyl) adenines, the method of preparation and utilization thereof
JP2543822B2 (ja) グアニン誘導体
JPH0725760B2 (ja) 抗ウイルス性化合物
WO1987005604A1 (en) 2-aminopurine derivatives and process for their preparation
EP0145739B1 (en) Novel antiviral agents
JPH0822866B2 (ja) プリンおよびピリミジン塩基のｎ−ホスホニルメトキシアルキル誘導体
JPS6147839B2 (enEXAMPLES)
JPS63297381A (ja) ９−〔２−（ヒドロキシメチル）シクロアルキルメチル〕グアニン類
US4670424A (en) Cyclic pyrophosphates of purine and pyrimidine acyclonucleosides
US4845084A (en) Phosphate derivatives of substituted butyl guanines, antiviral compositions containing them, and methods of treating viral infections with them
EP0138683A2 (en) Purine derivatives, their application in anti-viral compositions
NO880606L (no) Nukleotidanaloger og fremgangsmaate for deres fremstilling.
US4897479A (en) Arylsulfonyloxy purine intermediates
NO833526L (no) Fremgangsmaate for fremstilling av guanidinderivater med anti-virus-virkning
DK149026B (da) Analogifremgangsmaade til fremstilling af adeninnucleosidderivater
KR840002462B1 (ko) 아릴알킬-및 아릴옥시알킬포스포네이트의 제조방법
CA1287832C (en) Anti-viral compounds
US4880820A (en) Guanine derivatives
HU196406B (en) Process for production of derivatives of carbocyclic purin nucleorides and medical preparatives containing them
CS247688B1 (cs) Způsob výroby soli lysinu s kyselinou acetylsalicylovou
JPH02188A (ja) ヌクレオチド類縁体およびその製造法，ならびに抗ウイルス剤
JPH03218392A (ja) オキセタノシン類のリン酸エステル、その用途およびその製造法
JPH03161488A (ja) 光学活性シクロペンタン誘導体およびその製造法
JPS62174097A (ja) ヌクレオシド類縁体およびその製造法、ならびに抗ウイルス剤